coronaviru
includ
sar
mer
caus
two
largescal
pandem
last
two
decad
although
viral
evas
host
immun
respons
virusinduc
cytopath
effect
believ
critic
diseas
sever
studi
human
die
sar
anim
model
suggest
excess
aberr
host
cytokin
storm
result
exuber
immunopatholog
lethal
diseas
inflammatori
cytokin
storm
refer
immun
system
gone
awri
excess
inflammatori
respons
flare
control
cytokin
storm
associ
wide
varieti
infecti
noninfecti
diseas
includ
graftversushost
diseas
autoimmun
diseas
sever
viru
infect
multipl
organ
dysfunct
syndrom
chimer
antigen
receptor
car
cell
therapi
report
follow
sarscov
infect
dysregul
cytokinechemokin
respons
higher
viru
titer
caus
inflammatori
cytokin
storm
lung
immunopatholog
injuri
inflamm
associ
cytokin
storm
may
begin
one
local
site
spread
throughout
bodi
via
system
circul
similarli
patient
infect
report
recent
increas
plasma
concentr
inflamm
relat
cytokin
includ
interleukin
il
granulocytecoloni
stimul
factor
gcsf
protein
monocyt
chemoattract
protein
macrophag
inflammatori
protein
alpha
tumour
necrosi
factor
especi
moribund
patient
importantli
patient
develop
characterist
pulmonari
ground
glass
chang
imag
peripher
lymphocyt
decreas
importantli
larg
number
inflammatori
immun
cell
infiltr
also
found
patient
pulmonari
patholog
phenomena
suggest
sever
pulmonari
inflamm
cytokin
storm
also
exist
infect
present
symptomat
treatment
organ
support
moribund
patient
mainstay
clinic
manag
urgent
identifi
immunopatholog
mechan
delay
pulmonari
immun
injuri
patient
infect
sarscov
report
sever
pulmonari
immun
injuri
correl
extens
infiltr
neutrophil
macrophag
lung
accompani
increas
number
neutrophil
monocyt
lower
cell
count
peripher
blood
sampl
identifi
immun
characterist
patient
infect
peripher
blood
sampl
patient
sever
pneumonia
collect
immun
analysi
consist
previou
clinic
characterist
report
e
activationinduc
costimulatori
molecul
import
prime
immun
respons
cytotox
cell
icu
patient
infect
express
increas
significantli
compar
healthi
control
supplementari
fig
e
report
coexpress
may
repres
subset
cell
sever
exhaust
viru
infect
worth
note
much
higher
percentag
coexpress
subset
exist
cell
patient
supplementari
fig
especi
icu
patient
suggest
exhaust
statu
cell
patient
infect
identifi
key
pathogen
cytokin
main
sourc
cytokin
granulocytemacrophag
colonystimul
factor
gmcsf
select
analyz
intracellular
cytokin
stain
inflammatori
mediat
proven
critic
primari
caus
inflammatori
cytokin
storm
patient
infect
sarscov
merscov
without
restimul
pma
incub
monensin
high
percentag
gmcsf
express
could
found
cell
patient
icu
nonicu
patient
compar
healthi
control
fig
c
icu
patient
sever
pneumonia
show
correl
higher
percentag
gmcsf
cell
fig
c
pathogen
cell
gmcsf
express
report
central
nervou
system
inflamm
importantli
aberr
pathogen
cell
coexpress
gmcsf
exist
icu
patient
infect
wherea
littl
found
nonicu
patient
healthi
control
indic
pathogen
cell
correl
evid
patient
sever
diseas
play
critic
role
hyperinflammatori
respons
pathogenesi
fig
meanwhil
significantli
upregul
cell
patient
supplementari
fig
b
cell
icu
patient
also
show
higher
express
gmcsf
compar
nonicu
patient
healthi
control
found
cell
supplementari
fig
neither
nk
cell
b
cell
secret
sourc
gmcsf
supplementari
fig
gmcsf
recent
involv
pathogenesi
inflammatori
autoimmun
diseas
mechan
control
divers
pathogen
capabl
inflammatori
myeloid
cell
among
myeloid
cell
monocyt
pathogen
gmcsf
respons
cell
requir
gmcsf
initi
tissu
damag
mous
human
identifi
whether
inflammatori
monocyt
exist
patient
phenotyp
subpopul
monocyt
analysi
inflammatori
monocyt
subset
seldom
exist
healthi
control
contrast
significantli
higher
percentag
inflammatori
monocyt
exist
peripher
blood
patient
percentag
monocyt
much
higher
sever
pulmonari
syndrom
patient
icu
fig
c
moreov
monocyt
patient
also
show
capabl
secret
gmcsf
importantli
significantli
higher
express
secret
inflammatori
monocyt
especi
icu
patient
let
inflammatori
storm
even
wors
fig
meanwhil
number
gmcsf
monocyt
monocyt
increas
rapidli
fig
suggest
potenti
high
risk
inflammatori
cytokin
storm
caus
monocyt
may
migrat
lung
develop
macrophag
monocyt
deriv
dendrit
cell
thu
patient
gmcsf
potenti
link
sever
pulmonari
syndromeiniti
capac
pathogen
cell
gmcsf
inflammatori
signatur
monocyt
high
express
progeni
activ
immun
cell
may
enter
pulmonari
circul
larg
number
play
immun
damag
role
sever
pulmonari
syndrom
patient
fig
studi
provid
detail
immunopatholog
report
suggest
excess
activ
immun
respons
caus
pathogen
gmcsf
cell
inflammatori
monocyt
may
connect
pulmonari
immunopatholog
lead
deleteri
clinic
manifest
even
acut
mortal
infect
consist
situat
sarscov
merscov
remark
children
alway
experi
mildmoder
clinic
ill
elderli
individu
exhibit
wors
outcom
infect
indic
matur
excess
immun
respons
toward
pathogen
human
coronaviru
infect
play
key
role
induc
sever
pulmonari
syndrom
even
organ
failur
specif
new
drug
target
may
take
long
time
evalu
develop
critic
moment
sever
market
drug
target
inflammatori
storm
reduc
immunopatholog
could
consid
tocilizumab
specif
bind
membran
bound
receptor
solubl
receptor
inhibit
signal
transduct
first
block
antibodi
approv
market
prove
safeti
effect
therapi
rheumatoid
arthriti
order
verifi
whether
target
receptor
inflammatori
signal
may
potenti
right
way
save
sever
patient
launch
clinic
trial
use
tocilizumab
block
interleukin
receptor
sever
patient
recruit
right
inspir
clinic
result
includ
quickli
decreas
temperatur
respiratori
function
improv
mani
urgent
question
remain
answer
evid
alveolar
wash
fluid
organ
autopsi
patient
need
verifi
whether
aberr
pathogen
immun
cell
play
fatal
immun
damag
caus
organ
function
disabl
mortal
detail
see
supplementari
data
supplementari
data
avail
nsr
onlin
repres
densiti
plot
show
analysi
gmcsf
express
gate
monocyt
cell
isol
peripher
blood
healthi
control
icu
nonicu
patient
c
statist
calcul
percentag
subset
monocyt
statist
calcul
percentag
gmcsf
cell
monocyt
e
statist
calcul
cell
number
gmcsf
monocyt
data
repres
mean
sem
oneway
anova
p
consid
statist
signific
pathogen
gmcsf
cell
rapidli
activ
produc
gmcsf
inflammatori
cytokin
form
cascad
signatur
inflammatori
monocyt
high
express
progeni
activ
immun
cell
may
enter
pulmonari
circul
larg
number
play
immun
damag
role
sever
pulmonari
syndrom
patient
monoclon
antibodi
target
gmcsf
interleukin
receptor
may
potenti
prevent
curb
immunopatholog
caus
